The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease.
While the ASC space is still largely fragmented and independent, consolidating forces have been making headway in the industry — and gastroenterology has not been spared.
In recent commentary published in the New England Journal of Medicine AI, researchers from the Massachusetts Institute of Technology in Cambridge, Equality AI and Boston University underscored the need for more regulation regarding both AI and non-AI a…